Teleflex Incorporated Stock

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:47:06 2024-05-08 pm EDT 5-day change 1st Jan Change
200.2 USD -0.67% Intraday chart for Teleflex Incorporated -5.81% -20.09%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.09B Sales 2025 * 3.26B Capitalization 9.49B
Net income 2024 * 409M Net income 2025 * 543M EV / Sales 2024 * 3.42 x
Net Debt 2024 * 1.06B Net Debt 2025 * 507M EV / Sales 2025 * 3.07 x
P/E ratio 2024 *
26 x
P/E ratio 2025 *
17.9 x
Employees 14,500
Yield 2024 *
0.68%
Yield 2025 *
0.68%
Free-Float 97.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.28%
1 week-3.46%
Current month-3.46%
1 month-7.04%
3 months-19.68%
6 months-1.61%
Current year-19.18%
More quotes
1 week
198.21
Extreme 198.205
213.41
1 month
198.21
Extreme 198.205
223.94
Current year
198.21
Extreme 198.205
256.85
1 year
177.63
Extreme 177.633
262.97
3 years
177.63
Extreme 177.633
428.36
5 years
177.63
Extreme 177.633
449.38
10 years
101.95
Extreme 101.95
449.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 08-12-31
Director of Finance/CFO 62 11-07-31
Compliance Officer - 17-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-12-31
Director/Board Member 64 08-12-31
Director/Board Member 69 18-12-31
More insiders
Date Price Change Volume
24-05-08 199.3 -1.12% 195 846
24-05-07 201.5 +0.28% 462,601
24-05-06 201 -1.01% 551,439
24-05-03 203 +2.15% 604,098
24-05-02 198.7 -6.06% 706,549

Delayed Quote Nyse, May 07, 2024 at 04:00 pm EDT

More quotes
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
201.5 USD
Average target price
245.2 USD
Spread / Average Target
+21.69%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW